Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio's strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/05/18 | $100,000,000 | Seed and Series A |
ARCH Venture Partners Omega Funds | undisclosed |
